Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
Acta Pharmacol Sin
; 42(7): 1180-1189, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-33149145
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Proto-Oncogene Proteins
/
Cisplatin
/
Receptor Protein-Tyrosine Kinases
/
Glycolysis
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos